CTI BioPharma Corp.
CTIC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30 | $65 | $40 | $31 |
| Short-Term Investments | $50 | $0 | $12 | $3 |
| Receivables | $15 | $0 | $0 | $0 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $2 | $2 |
| Total Curr. Assets | $99 | $68 | $54 | $36 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $23 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $6 |
| Total NC Assets | $27 | $4 | $4 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $126 | $72 | $58 | $46 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $2 | $0 |
| Short-Term Debt | $48 | $49 | $4 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $14 | $7 | $0 |
| Other Curr. Liab. | $31 | $14 | $11 | $14 |
| Total Curr. Liab. | $81 | $67 | $17 | $18 |
| LT Debt | $0 | $2 | $1 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $62 | $0 | $0 | $2 |
| Total NC Liab. | $62 | $2 | $1 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $144 | $69 | $18 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,519 | -$2,426 | -$2,328 | -$2,264 |
| AOCI | -$0 | $0 | $0 | -$12 |
| Other Equity | $2,501 | $2,430 | $2,368 | $2,293 |
| Total Equity | -$18 | $4 | $40 | $18 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | -$6 |
| Total Liab. & Tot. Equity | $126 | $72 | $58 | $46 |
| Net Debt | $18 | -$15 | -$35 | -$19 |